tiprankstipranks
Trending News
More News >
Solasia Pharma KK (DE:9SO)
:9SO
Germany Market

Solasia Pharma KK (9SO) Income Statement

Compare
0 Followers

Solasia Pharma KK Income Statement

Last quarter (Q1 2025), Solasia Pharma KK's total revenue was ¥25.00M, an increase of 127.27% from the same quarter last year. In Q1, Solasia Pharma KK's net income was ¥-292.00M. See Solasia Pharma KK’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 316.00M¥ 617.00M¥ 1.09B¥ 559.00M¥ 454.00M
Gross Profit
¥ 185.00M¥ 337.00M¥ 662.00M¥ 374.00M¥ 245.00M
Operating Expenses
¥ 2.14B¥ 1.48B¥ 3.13B¥ 2.79B¥ 4.36B
Depreciation and Amortization
¥ 195.00M¥ 500.00M¥ 534.00M¥ 495.00M¥ 496.00M
EBITDA
¥ -1.75B¥ -635.00M¥ -1.94B¥ -1.92B¥ -3.62B
Operating Income
¥ -1.95B¥ -1.14B¥ -2.47B¥ -2.42B¥ -4.12B
Other Income/Expenses
¥ -9.00M¥ 4.00M¥ -21.00M¥ -23.00M¥ -44.00M
Pretax Income
¥ -1.96B¥ -1.14B¥ -2.49B¥ -2.44B¥ -4.16B
Net Income
¥ -1.94B¥ -1.11B¥ -2.55B¥ -2.48B¥ -4.13B
Per Share Metrics
Basic EPS
¥ -9.77¥ -6.61¥ -16.76¥ -19.03¥ -35.16
Diluted EPS
¥ -9.77¥ -6.61¥ -16.76¥ -19.03¥ -35.16
Weighted Average Shares Outstanding
198.67M 168.13M 151.99M 130.15M 117.38M
Weighted Average Shares Outstanding (Diluted)
198.70M 168.13M 151.99M 130.15M 117.38M
Currency in JPY

Solasia Pharma KK Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis